Top 10 Companies in the Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market (2026): Market Leaders Powering Global Longevity

MARKET INSIGHTS

The Global raw materials for longevity drug NMN (Nicotinamide Mononucleotide) market was valued at USD 468 million in 2025. The market is projected to grow from USD 532 million in 2026 to USD 1163 million by 2034, exhibiting a compound annual growth rate (CAGR) of 14.1% during the forecast period. In 2025, global production reached approximately 1,700 tons, with a total installed production capacity of 2,100 tons, highlighting a robust and expanding industrial base. The average global market price for NMN raw materials was approximately USD 300,000 per ton, and the industry maintained a healthy average gross profit margin of 36%.

Nicotinamide mononucleotide (NMN) is a naturally occurring bioactive nucleotide that serves as a direct precursor to nicotinamide adenine dinucleotide (NAD+), a vital coenzyme essential for cellular energy metabolism. Its molecular structure comprises a nicotinamide group, a ribose sugar, and a phosphate group. The core scientific premise driving its market is the significant decline in NAD+ levels associated with aging, which is linked to a deterioration of cellular functions. Supplementation with NMN is posited to efficiently elevate NAD+ levels, thereby activating sirtuins, a family of proteins critical for longevity that regulate processes like DNA repair and mitochondrial health.

The market’s significant growth is propelled by increasing global consumer focus on healthspan extension and anti‑aging solutions, coupled with rising disposable incomes. Furthermore, advancements in production technologies, particularly enzymatic catalysis, are improving yields and reducing costs, making NMN more accessible. However, the market’s trajectory is heavily influenced by the evolving regulatory landscape, especially in key regions like China and the United States, where approvals for use in dietary supplements and health products are pivotal. Ongoing clinical trials to substantiate NMN’s efficacy in humans represent a critical factor that will shape future market acceptance and potential expansion into pharmaceutical applications.

Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market – View in Detailed Research Report

Top 10 Companies in the Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market (2026)

1️⃣ Herbalmax

Headquarters: New York, United States
Key Offering: High‑purity NMN raw material for dietary supplements and pharmaceutical APIs

Herbalmax has positioned itself as a leading supplier of GMP‑certified NMN, leveraging advanced chemical synthesis and rigorous purification processes to achieve purity levels exceeding 98%. The company’s portfolio includes both bulk raw material and custom formulation services for global supplement brands.

Sustainability & Growth Initiatives:

• Investing in renewable feedstock sourcing to reduce carbon footprint.
• Implementing closed‑loop water recycling in manufacturing plants.
• Partnering with academic institutions for clinical validation studies.

2️⃣ Bontac

Headquarters: Shanghai, China
Key Offering: Enzyme‑catalyzed NMN synthesis and large‑scale production

Bontac’s proprietary enzymatic process achieves high yield and purity while minimizing hazardous waste. The company serves a broad portfolio of pharmaceutical and nutraceutical manufacturers across Asia and Europe.

Sustainability & Growth Initiatives:

• Adoption of green chemistry principles in upstream processes.
• Expansion of production capacity to 2,500 tons by 2028.
• Strategic alliances with global distributors to broaden market reach.

3️⃣ Genex Formulas

Headquarters: Los Angeles, United States
Key Offering: High‑purity NMN for premium health supplement brands

Genex Formulas focuses on delivering pharmaceutical‑grade NMN with a purity of 99.5%. Their robust quality assurance program includes heavy metal testing and GMP compliance, ensuring consistency for high‑end brands.

Sustainability & Growth Initiatives:

• Development of biodegradable packaging for raw material shipments.
• Implementation of energy‑efficient production lines.
• Investment in R&D for next‑generation NMN derivatives.

4️⃣ Maac10 Formulas

Headquarters: San Diego, United States
Key Offering: Custom synthesis of NMN with tailored purity and dosage forms

Maac10 specializes in flexible manufacturing, offering both bulk and formulation services. Their modular production units allow rapid scale‑up to meet seasonal demand spikes.

Sustainability & Growth Initiatives:

• Adoption of digital twins for process optimization.
• Participation in industry sustainability certification programs.
• Collaboration with NGOs to promote health education in underserved regions.

5️⃣ GeneHarbor

Headquarters: Hong Kong
Key Offering: Fermentation‑based NMN production with high yield and low environmental impact

GeneHarbor utilizes advanced microbial fermentation to produce NMN, achieving a 30% higher yield than conventional chemical routes while reducing hazardous waste.

Sustainability & Growth Initiatives:

• Use of renewable biomass as feedstock.
• Implementation of zero‑waste policies across all facilities.
• Expansion of R&D into related NAD+ precursors.

6️⃣ CELFULL

Headquarters: Tokyo, Japan
Key Offering: Ultra‑pure NMN for cosmetics and functional foods

CELFULL supplies NMN with a purity of 99.8%, catering to the Japanese and Korean cosmetics markets that demand the highest quality ingredients for anti‑aging skincare.

Sustainability & Growth Initiatives:

• Implementation of water‑less production techniques.
• Certification under ISO 14001 environmental management.
• Strategic partnership with leading cosmetic brands for co‑development.

7️⃣ Zhongsheng Pharmaceutical

Headquarters: Wuhan, China
Key Offering: Bulk NMN for pharmaceutical APIs and large‑scale dietary supplements

Zhongsheng Pharmaceutical operates one of the largest NMN production facilities in China, focusing on cost‑effective chemical synthesis while maintaining strict GMP standards.

Sustainability & Growth Initiatives:

• Investment in green energy to power manufacturing units.
• Development of eco‑friendly packaging solutions.
• Expansion of export channels to Southeast Asia and Europe.

8️⃣ Mirailab Bioscience

Headquarters: Seoul, South Korea
Key Offering: High‑purity NMN with customizable purity grades for research and industrial use

Mirailab Bioscience offers a range of purity levels (95–99.5%) to serve both academic research institutions and commercial manufacturers.

Sustainability & Growth Initiatives:

• Use of biodegradable solvents in synthesis.
• Participation in regional sustainability forums.
• Collaboration with universities for clinical studies.

9️⃣ EffePharm

Headquarters: Shenzhen, China
Key Offering: Enzyme‑catalyzed NMN with rapid turnaround for emerging markets

EffePharm focuses on fast‑track production, enabling quick response to market demand spikes, especially in the burgeoning Chinese supplement sector.

Sustainability & Growth Initiatives:

• Implementation of waste‑to‑energy systems.
• Strategic partnership with logistics firms for efficient distribution.
• Investment in AI‑driven quality control.

🔟 Kingdomway

Headquarters: Guangzhou, China
Key Offering: Bulk NMN for international pharmaceutical and nutraceutical markets

Kingdomway supplies high‑purity NMN to global pharmaceutical manufacturers, maintaining strict compliance with international GMP and ISO standards.

Sustainability & Growth Initiatives:

• Adoption of renewable energy sources across all plants.
• Implementation of circular economy practices.
• Expansion of R&D into combination therapies with other NAD+ boosters.

Download FREE Sample Report

Get Full Report

Outlook: The Future of NMN Raw Materials is Expanding and Innovative

The NMN raw materials market is set to witness transformative growth driven by regulatory approvals, technological breakthroughs, and expanding therapeutic applications. As global health authorities increasingly recognize NMN’s clinical potential, the market is poised for a shift from dietary supplements to pharmaceutical APIs, unlocking new revenue streams for high‑purity suppliers.

Future Trends

• Accelerated adoption of enzymatic and fermentation processes to reduce costs and improve sustainability.
• Regulatory reclassification of NMN as a health‑food or drug ingredient in key markets, broadening market access.
• Emergence of combination products pairing NMN with other anti‑aging nutraceuticals for enhanced efficacy.
• Increased focus on personalized dosage forms and targeted delivery systems.
• Growth of digital health platforms integrating NMN supplementation with wellness tracking.